Technology: Naked Biome’s drug discovery platform uses next-generation sequencing to profile healthy and diseased skin to identify unique microbial signatures that naturally aid in the defense against acne. Our multidisciplinary team of leading physicians, scientists, and industry experts are developing innovative approaches to expand the platform’s reach to discover probiotic treatments for other skin diseases with a microbial component including eczema, psoriasis and rosacea.
We’ve been selected to be a part of the Illumina Accelerator, allowing us access to the most advanced sequencing technologies and expertise.
Why now? The Human Microbiome project, initiated in 2009, has created a great foundation of information and technology, which is the basis of our new discoveries and solutions. Naked Biome’s ability to expand our database and advance clinical discoveries in human health is driven by the rapidly decreasing sequencing costs and readily accessible skin samples.
Illumina Accelerator, a business accelerator focused solely on creating an innovation ecosystem for the genomics industry—has selected four new investments from its third funding cycle.
– Naked Biome, a skin microbiome company formed by faculty members from the University of California, Los Angeles, is harnessing genomics information from the cutaneous microbiome to create advances in skin care, with a current focus on acne.